The Eph/Ephrin family in cancer metastasis: Communication at the service of invasion

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 353-373

  Kandouz, Mustapha ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Adhesion; Cancer; Communication; Eph; Ephrin; Invasion; Metastasis; Oncogene; Receptor tyrosine kinase; Tumor suppressor

Indexed keywords

EPHRIN; EPHRIN A1; EPHRIN B2; LIGAND; PROTEIN ERYTHROPOIETIN PRODUCING HEPATOMA; PROTEIN ERYTHROPOIETIN PRODUCING HEPATOMA A2; PROTEIN ERYTHROPOIETIN PRODUCING HEPATOMA A3; PROTEIN ERYTHROPOIETIN PRODUCING HEPATOMA B4; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; COLORECTAL CANCER; CYTOSKELETON; DISEASE ASSOCIATION; ENDOCYTOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GLIOBLASTOMA; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL COMMUNICATION; EPHRINS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; RECEPTORS, EPH FAMILY; SIGNAL TRANSDUCTION;

EID: 84862322993     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9352-1     Document Type: Review

References (184)

1. Naus, C. C., & Laird, D. W. (2010). Implications and challenges of connexin connections to cancer. Nature Reviews. Cancer, 10, 435-441.
2. Kandouz, M., & Batist, G. (2010). Gap junctions and connexins as therapeutic targets in cancer. Expert Opinion on Therapeutic Targets, 14, 681-692.
3. Martin, T. A., Mason,M. D., & Jiang,W. G. (2011). Tight junctions in cancer metastasis. Frontiers in Bioscience, 16, 898-936.
4. Dusek, R. L., & Attardi, L. D. (2011). Desmosomes: new perpetrators in tumour suppression. Nature Reviews. Cancer, 11, 317-323.
5. Yang, S. Y., Miah, A., Pabari, A., & Winslet, M. (2011). Growth factors and their receptors in cancer metastases. Frontiers in Bioscience, 16, 531-538.
6. Al-Nedawi, K., Meehan, B., & Rak, J. (2009). Microvesicles: messengers and mediators of tumor progression. Cell Cycle, 8, 2014-2018.
7. Oricchio, E., Nanjangud, G.,Wolfe, A. L., Schatz, J. H., Mavrakis, K. J., Jiang, M., et al. (2011). The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell, 147, 554-564.
8. Aasheim, H. C., Munthe, E., Funderud, S., Smeland, E. B., Beiske, K., & Logtenberg, T. (2000). A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood, 95, 221-230. (Pubitemid 30017246)
9. Dahmann, C., Oates, A. C., & Brand, M. (2011). Boundary formation and maintenance in tissue development. Nature Reviews Genetics, 12, 43-55.
10. Melani, M., & Weinstein, B. M. (2010). Common factors regulating patterning of the nervous and vascular systems. Annual Review of Cell and Developmental Biology, 26, 639-665.
11. Egea, J., & Klein, R. (2007). Bidirectional Eph-ephrin signaling during axon guidance. Trends in Cell Biology, 17, 230-238. (Pubitemid 46679245)
12. Palmer, A., & Klein, R. (2003). Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes & Development, 17, 1429-1450. (Pubitemid 36734700)
13. Solanas, G., & Batlle, E. (2011). Control of cell adhesion and compartmentalization in the intestinal epithelium. Experimental Cell Research, 317, 2695-2701.
14. Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernandez-Masip, J. L., Vivancos, A., Whissell, G., et al. (2007). EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nature Genetics, 39, 1376-1383. (Pubitemid 350034995)
15. Noren, N. K., Foos, G., Hauser, C. A., & Pasquale, E. B. (2006). The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nature Cell Biology, 8, 815-825. (Pubitemid 44151584)
16. Guo, H., Miao, H., Gerber, L., Singh, J., Denning, M. F., Gilliam, A. C., et al. (2006). Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Research, 66, 7050-7058. (Pubitemid 44197681)
17. Shi, L., Itoh, F., Itoh, S., Takahashi, S., Yamamoto, M., & Kato, M. (2008). Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc(min/+) mice. Oncogene, 27, 3265-3273. (Pubitemid 351733392)
18. Li, J. J., Liu, D. P., Liu, G. T., & Xie, D. (2009). EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor. Oncogene, 28, 1759-1768.
19. Udayakumar, D., Zhang, G., Ji, Z., Njauw, C. N., Mroz, P., & Tsao, H. (2011). Epha2 is a critical oncogene in melanoma. Oncogene, 30, 4921-4929.
20. Zhang, J., & Hughes, S. (2006). Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. The Journal of Pathology, 208, 453-461. (Pubitemid 43329333)
21. Aitsebaomo, J., Portbury, A. L., Schisler, J. C., & Patterson, C. (2008). Brothers and sisters: molecular insights into arterialvenous heterogeneity. Circulation Research, 103, 929-939.
22. Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., et al. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/ venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes & Development, 13, 295-306. (Pubitemid 29095801)
23. Gerety, S. S.,Wang, H. U., Chen, Z. F., & Anderson, D. J. (1999). Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Molecular Cell, 4, 403-414. (Pubitemid 29499793)
24. Wang, H. U., Chen, Z. F., & Anderson, D. J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell, 93, 741-753. (Pubitemid 28257581)
25. Foo, S. S., Turner, C. J., Adams, S., Compagni, A., Aubyn, D., Kogata, N., et al. (2006). Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell, 124, 161-173. (Pubitemid 43069317)
26. Salvucci, O., Maric, D., Economopoulou, M., Sakakibara, S., Merlin, S., Follenzi, A., et al. (2009). EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood, 114, 1707-1716.
27. Gale, N. W., Baluk, P., Pan, L., Kwan, M., Holash, J., DeChiara, T. M., et al. (2001). Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Developmental Biology, 230, 151-160. (Pubitemid 32171414)
28. Shin, D., Garcia-Cardena, G., Hayashi, S., Gerety, S., Asahara, T., Stavrakis, G., et al. (2001). Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Developmental Biology, 230, 139-150. (Pubitemid 32171413)
29. Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M., & Pasquale, E. B. (2004). Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 101, 5583-5588. (Pubitemid 38481199)
30. Bochenek, M. L., Dickinson, S., Astin, J. W., Adams, R. H., & Nobes, C. D. (2010). Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. Journal of Cell Science, 123, 1235-1246.
31. Sawai, Y., Tamura, S., Fukui, K., Ito, N., Imanaka, K., Saeki, A., et al. (2003). Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization. Journal of Hepatology, 39, 991-996. (Pubitemid 37523771)
32. Vogt, T., Stolz, W., Welsh, J., Jung, B., Kerbel, R. S., Kobayashi, H., et al. (1998). Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clinical Cancer Research, 4, 791-797. (Pubitemid 28193580)
33. Hainaud, P., Contreres, J. O., Villemain, A., Liu, L. X., Plouet, J., Tobelem, G., et al. (2006). The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Research, 66, 8501-8510. (Pubitemid 44449163)
34. Haldimann, M., Custer, D., Munarini, N., Stirnimann, C., Zurcher, G., Rohrbach, V., et al. (2009). Deregulated ephrin-B2 expression in the mammary gland interferes with the development of both the glandular epithelium and vasculature and promotes metastasis formation. International Journal of Oncology, 35, 525-536.
35. Brantley-Sieders, D. M., Fang, W. B., Hwang, Y., Hicks, D., & Chen, J. (2006). Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Cancer Research, 66, 10315-10324. (Pubitemid 44799750)
36. Kataoka, H., Igarashi, H., Kanamori, M., Ihara, M., Wang, J. D., Wang, Y. J., et al. (2004). Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer. Cancer Science, 95, 136-141. (Pubitemid 38404314)
37. Brantley-Sieders, D. M., Caughron, J., Hicks, D., Pozzi, A., Ruiz, J. C., & Chen, J. (2004). EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. Journal of Cell Science, 117, 2037-2049. (Pubitemid 38745137)
38. Brantley-Sieders, D. M., Fang, W. B., Hicks, D. J., Zhuang, G., Shyr, Y., & Chen, J. (2005). Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. The FASEB Journal, 19, 1884-1886. (Pubitemid 41598783)
39. Hunter, S. G., Zhuang, G., Brantley-Sieders, D., Swat, W., Cowan, C. W., & Chen, J. (2006). Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Molecular and Cellular Biology, 26, 4830-4842. (Pubitemid 43955801)
40. Fang, W. B., Brantley-Sieders, D. M., Hwang, Y., Ham, A. J., & Chen, J. (2008). Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. Journal of Biological Chemistry, 283, 16017-16026.
41. Deroanne, C., Vouret-Craviari, V., Wang, B., & Pouyssegur, J. (2003). EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway. Journal of Cell Science, 116, 1367-1376. (Pubitemid 36410674)
42. Cheng, N., Brantley, D. M., Liu, H., Lin, Q., Enriquez, M., Gale, N., et al. (2002). Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Molecular Cancer Research, 1, 2-11. (Pubitemid 36330206)
43. Wang, Y., Nakayama, M., Pitulescu, M. E., Schmidt, T. S., Bochenek, M. L., Sakakibara, A., et al. (2010). Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature, 465, 483-486.
44. Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., et al. (2010). Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature, 465, 487-491.
45. Salvucci, O., de la Luz, S. M., Martina, J. A., McCormick, P. J., & Tosato, G. (2006). EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood, 108, 2914-2922.
46. Dunaway, C. M., Hwang, Y., Lindsley, C. W., Cook, R. S., Wu, J. Y., Boothby, M., et al. (2011). Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis. Molecular and Cellular Biology, 31, 404-416.
47. Vihanto, M. M., Plock, J., Erni, D., Frey, B. M., Frey, F. J., & Huynh-Do, U. (2005). Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. The FASEB Journal, 19, 1689-1691. (Pubitemid 41429531)
48. Tachibana, M., Tonomoto, Y., Hyakudomi, R., Hyakudomi, M., Hattori, S., Ueda, S., et al. (2007). Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Digestive and Liver Disease, 39, 725-732. (Pubitemid 47046642)
49. Oshima, T., Akaike, M., Yoshihara, K., Shiozawa, M., Yamamoto, N., Sato, T., et al. (2008). Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer. International Journal of Oncology, 33, 573-577.
50. Ji, X. D., Li, G., Feng, Y. X., Zhao, J. S., Li, J. J., Sun, Z. J., et al. (2011). EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration. Cancer Research, 71, 1156-1166.
51. Huusko, P., Ponciano-Jackson, D., Wolf, M., Kiefer, J. A., Azorsa, D. O., Tuzmen, S., et al. (2004). Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genetics, 36, 979-983. (Pubitemid 39167494)
52. Guo, D. L., Zhang, J., Yuen, S. T., Tsui, W. Y., Chan, A. S., Ho, C., et al. (2006). Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis, 27, 454-464. (Pubitemid 43372874)
53. Mudali, S. V., Fu, B., Lakkur, S. S., Luo, M., Embuscado, E. E., & Iacobuzio-Donahue, C. A. (2006). Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status. Clinical & Experimental Metastasis, 23, 357-365. (Pubitemid 46197118)
54. Yu, J., Bulk, E., Ji, P., Hascher, A., Koschmieder, S., Berdel, W. E., et al. (2009). The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma. International Journal of Oncology, 35, 175-179.
55. Yu, J., Bulk, E., Ji, P., Hascher, A., Tang, M., Metzger, R., et al. (2010). The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer. Clinical Cancer Research, 16, 2275-2283.
56. Parri, M., Buricchi, F., Giannoni, E., Grimaldi, G., Mello, T., Raugei, G., et al. (2007). EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility. Journal of Biological Chemistry, 282, 19619-19628. (Pubitemid 47100120)
57. Huang, X., Wu, D., Jin, H., Stupack, D., & Wang, J. Y. (2008). Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. The Journal of Cell Biology, 183, 711-723.
58. Smith, L. M., Walsh, P. T., Rudiger, T., Cotter, T. G., Mc Carthy, T. V., Marx, A., et al. (2004). EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion. Experimental Cell Research, 292, 295-303. (Pubitemid 38018845)
59. Lawrenson, I. D., Wimmer-Kleikamp, S. H., Lock, P., Schoenwaelder, S. M., Down, M., Boyd, A. W., et al. (2002). Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. Journal of Cell Science, 115, 1059-1072. (Pubitemid 34257389)
60. Campbell, T. N., Attwell, S., Rcellana-Panlilio, M., & Robbins, S. M. (2006). Ephrin A5 expression promotes invasion and transformation of murine fibroblasts. Biochemical and Biophysical Research Communications, 350, 623-628. (Pubitemid 44547894)
61. Nakada, M., Drake, K. L., Nakada, S., Niska, J. A., & Berens, M. E. (2006). Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Research, 66, 8492-8500. (Pubitemid 44449162)
62. Nakada, M., Anderson, E. M., Demuth, T., Nakada, S., Reavie, L. B., Drake, K. L., et al. (2010). The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. International Journal of Cancer, 126, 1155-1165.
63. Yang, N. Y., Pasquale, E. B., Owen, L. B., & Ethell, I. M. (2006). The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization. Journal of Biological Chemistry, 281, 32574-32586. (Pubitemid 46036812)
64. Clifford, N., Smith, L. M., Powell, J., Gattenlohner, S.,Marx, A., & O'Connor, R. (2008). The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration. Journal of Cellular Biochemistry, 105, 1250-1259.
65. Jiang, G., Freywald, T., Webster, J., Kozan, D., Geyer, R., DeCoteau, J., et al. (2008). In human leukemia cells ephrin- B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes. Molecular Cancer Research, 6, 291-305. (Pubitemid 351342417)
66. Meyer, S., Orso, E., Schmitz, G., Landthaler, M., & Vogt, T. (2007). Lubrol-RAFTs in melanoma cells: a molecular platform for tumor-promoting ephrin-B2-integrin-beta1 interaction. The Journal of Investigative Dermatology, 127, 1615-1621. (Pubitemid 46933437)
67. Julich, D., Mould, A. P., Koper, E., & Holley, S. A. (2009). Control of extracellular matrix assembly along tissue boundaries via Integrin and Eph/Ephrin signaling. Development, 136, 2913-2921.
68. Yamazaki, T., Masuda, J., Omori, T., Usui, R., Akiyama, H., & Maru, Y. (2009). EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. Journal of Cell Science, 122, 243-255.
69. Huai, J., & Drescher, U. (2001). An ephrin-A-dependent signaling pathway controls integrin function and is linked to the tyrosine phosphorylation of a 120-kDa protein. Journal of Biological Chemistry, 276, 6689-6694.
70. Davy, A., & Robbins, S. M. (2000). Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. EMBO Journal, 19, 5396-5405.
71. Miao, H., Burnett, E., Kinch, M., Simon, E., & Wang, B. (2000). Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nature Cell Biology, 2, 62-69.
72. Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004). Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochemical and Biophysical Research Communications, 320, 1096-1102. (Pubitemid 38916656)
73. Vindis, C., Teli, T., Cerretti, D. P., Turner, C. E., & Huynh-Do, U. (2004). EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. Journal of Biological Chemistry, 279, 27965-27970. (Pubitemid 38900065)
74. Buricchi, F., Giannoni, E., Grimaldi, G., Parri, M., Raugei, G., Ramponi, G., et al. (2007). Redox regulation of ephrin/integrin cross-talk. Cell Adhesion & Migration, 1, 33-42.
75. Gu, C., & Park, S. (2001). The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Molecular and Cellular Biology, 21, 4579-4597. (Pubitemid 32588241)
76. Huynh-Do, U., Stein, E., Lane, A. A., Liu, H., Cerretti, D. P., & Daniel, T. O. (1999). Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO Journal, 18, 2165-2173. (Pubitemid 29179173)
77. Watanabe,T., & Takahashi,Y. (2010) Tissue morphogenesis coupled with cell shape changes. Current Opinion in Genetics & Development.
78. Sahin, M., Greer, P. L., Lin, M. Z., Poucher, H., Eberhart, J., Schmidt, S., et al. (2005). Eph-dependent tyrosine phosphorylation of ephexin1modulates growth cone collapse. Neuron, 46, 191-204. (Pubitemid 40545776)
79. Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., et al. (2010). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Science, 101, 293-299.
80. Wells, A., Chao, Y. L., Grahovac, J.,Wu, Q., & Lauffenburger, D. A. (2011). Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Frontiers in Bioscience, 16, 815-837.
81. Lee, H. S., Nishanian, T. G., Mood, K., Bong, Y. S., & Daar, I. O. (2008). EphrinB1 controls cell-cell junctions through the Par polarity complex. Nature Cell Biology, 10, 979-986.
82. Zantek, N. D., Azimi, M., Fedor-Chaiken, M., Wang, B., Brackenbury, R., & Kinch, M. S. (1999). E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth & Differentiation, 10, 629-638. (Pubitemid 29455727)
83. Orsulic, S., & Kemler, R. (2000). Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. Journal of Cell Science, 113(Pt 10), 1793-1802. (Pubitemid 30333128)
84. Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M., Sancho, E., Huls, G., et al. (2002). Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell, 111, 251-263. (Pubitemid 35292445)
85. Solanas, G., Cortina, C., Sevillano, M., & Batlle, E. (2011). Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nature Cell Biology, 13, 1100-1107.
86. Chiu, S. T., Chang, K. J., Ting, C. H., Shen, H. C., Li, H., & Hsieh, F. J. (2009). Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis, 30, 1475-1486.
87. Barrios, A., Poole, R. J., Durbin, L., Brennan, C., Holder, N., & Wilson, S. W. (2003). Eph/Ephrin signaling regulates the mesenchymal-to- epithelial transition of the paraxial mesoderm during somite morphogenesis. Current Biology, 13, 1571-1582. (Pubitemid 37215881)
88. Hess, A. R., Seftor, E. A., Gruman, L. M., Kinch, M. S., Seftor, R. E., & Hendrix, M. J. (2006). VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biology & Therapy, 5, 228-233. (Pubitemid 43327544)
89. Tanaka, M., Kamata, R., & Sakai, R. (2005). Phosphorylation of ephrin-B1 via the interaction with claudin following cell-cell contact formation. EMBO Journal, 24, 3700-3711. (Pubitemid 41581687)
90. Tanaka, M., Kamata, R., & Sakai, R. (2005). EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. Journal of Biological Chemistry, 280, 42375-42382. (Pubitemid 43023209)
91. Walsh, R., & Blumenberg, M. (2012). EPH-2B, acting as an extracellular ligand, induces differentiation markers in epidermal keratinocytes. Journal of Cellular Physiology, 227, 2330-2340.
92. Davy, A., Bush, J. O., & Soriano, P. (2006). Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS.Biol, 4, e315.
93. Mellitzer, G., Xu, Q., & Wilkinson, D. G. (1999). Eph receptors and ephrins restrict cell intermingling and communication. Nature, 400, 77-81. (Pubitemid 29315114)
94. Adhikari, A. S., Agarwal, N., & Iwakuma, T. (2011). Metastatic potential of tumor-initiating cells in solid tumors. Frontiers in Bioscience, 16, 1927-1938.
95. Borovski, T., De Sousa Melo, E., Vermeulen, L., & Medema, J. P. (2011). Cancer stem cell niche: the place to be. Cancer Research, 71, 634-639.
96. Kaenel, P., Schwab, C., Mulchi, K., Wotzkow, C., & Andres, A. C. (2011). Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression. International Journal of Oncology, 38, 151-160.
97. Kaenel, P., Antonijevic, M., Richter, S., Kuchler, S., Sutter, N., Wotzkow, C., et al. (2012). Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway. International Journal of Oncology, 40, 357-369.
98. Holmberg, J., Genander,M., Halford,M.M., Anneren, C., Sondell, M., Chumley, M. J., et al. (2006). EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell, 125, 1151-1163. (Pubitemid 43866196)
99. Merlos-Suarez, A., Barriga, F. M., Jung, P., Iglesias, M., Cespedes, M. V., Rossell, D., et al. (2011). The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell, 8, 511-524.
100. Noren, N. K., & Pasquale, E. B. (2007). Paradoxes of the EphB4 receptor in cancer. Cancer Research, 67, 3994-3997. (Pubitemid 46815041)
101. Rutkowski, R., Mertens-Walker, I., Lisle, J. E., Herington, A. C., & Stephenson, S. A. (2012). Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. International Journal of Cancer. doi:10.1002/ijc.27392.
102. Kumar, S. R., Scehnet, J. S., Ley, E. J., Singh, J., Krasnoperov, V., Liu, R., et al. (2009). Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Research, 69, 3736-3745.
103. Heroult, M., Schaffner, F., Pfaff, D., Prahst, C., Kirmse, R., Kutschera, S., et al. (2010). EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinb2. Molecular Cancer Research, 8, 1297-1309.
104. Walsh, R., & Blumenberg, M. (2011). Specific and shared targets of ephrin A signaling in epidermal keratinocytes. Journal of Biological Chemistry, 286, 9419-9428.
105. Flanagan, J. G. (2006). Neural map specification by gradients. Current Opinion in Neurobiology, 16, 59-66.
106. Tanaka, M., Kamata, R., Takigahira, M., Yanagihara, K., & Sakai, R. (2007). Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma. American Journal of Pathology, 171, 68-78. (Pubitemid 47339227)
107. Miao, H., Strebhardt, K., Pasquale, E. B., Shen, T. L., Guan, J. L., & Wang, B. (2005). Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases. Journal of Biological Chemistry, 280, 923-932.
108. Hu, T., Shi, G., Larose, L., Rivera, G. M., Mayer, B. J., & Zhou, R. (2009). Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1. Biochemistry, 48, 6369-6378.
109. Huynh-Do, U., Vindis, C., Liu, H., Cerretti, D. P., McGrew, J. T., Enriquez, M., et al. (2002). Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. Journal of Cell Science, 115, 3073-3081.
110. Nakada, M., Niska, J. A., Miyamori, H., McDonough, W. S., Wu, J., Sato, H., et al. (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Research, 64, 3179-3185. (Pubitemid 38581420)
111. Miao, H., Li, D. Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., et al. (2009). EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell, 16, 9-20.
112. Kandouz, M., Haidara, K., Zhao, J., Brisson, M. L., & Batist, G. (2010). The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways. Cell Cycle, 9, 398-407.
113. Maddigan, A., Truitt, L., Arsenault, R., Freywald, T., Allonby, O., Dean, J., et al. (2011). EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes. Journal of Immunology, 187, 5983-5994.
114. Stahl, S., Branca, R. M., Efazat, G., Ruzzene, M., Zhivotovsky, B., Lewensohn, R., et al. (2011). Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor. Journal of Proteome Research, 10, 2566-2578.
115. Yang, N. Y., Fernandez, C., Richter, M., Xiao, Z., Valencia, F., Tice, D. A., et al. (2011). Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells. Cellular Signalling, 23, 201-212.
116. Brantley-Sieders, D. M., Zhuang, G., Hicks, D., Fang, W. B., Hwang, Y., Cates, J. M., et al. (2008). The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. The Journal of Clinical Investigation, 118, 64-78.
117. Fritsche-Guenther, R., Noske, A., Ungethum, U., Kuban, R. J., Schlag, P. M., Tunn, P. U., et al. (2010). De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway. Histopathology, 57, 836-850.
118. Poliakov, A., Cotrina, M. L., Pasini, A., & Wilkinson, D. G. (2008). Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway. The Journal of Cell Biology, 183, 933-947.
119. Fukai, J., Yokote, H., Yamanaka, R., Arao, T., Nishio, K., & Itakura, T. (2008). EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Molecular Cancer Therapeutics, 7, 2768-2778.
120. Larsen, A. B., Stockhausen, M. T., & Poulsen, H. S. (2010). Cell adhesion and EGFR activation regulate EphA2 expression in cancer. Cellular Signalling, 22, 636-644.
121. Larsen, A. B., Pedersen, M. W., Stockhausen, M. T., Grandal, M. V., Van, D. B., & Poulsen, H. S. (2007). Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Molecular Cancer Research, 5, 283-293. (Pubitemid 46569779)
122. Fox, B. P., & Kandpal, R. P. (2009). EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells. Oncogene, 28, 1706-1713.
123. Matsuoka, H., Obama, H., Kelly, M. L., Matsui, T., & Nakamoto, M. (2005). Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration. Journal of Biological Chemistry, 280, 29355-29363. (Pubitemid 41161391)
124. Freywald, A., Sharfe, N., & Roifman, C. M. (2002). The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. Journal of Biological Chemistry, 277, 3823-3828. (Pubitemid 34968631)
125. Truitt, L., & Freywald, A. (2011). Dancing with the dead: Eph receptors and their kinase-null partners. Biochemical Cell Biology, 89, 115-129.
126. Liu, D. P.,Wang, Y., Koeffler, H. P., & Xie, D. (2007). Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK. International Journal of Oncology, 30, 865-871.
127. Zhuang, G., Hunter, S., Hwang, Y., & Chen, J. (2007). Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation. Journal of Biological Chemistry, 282, 2683-2694. (Pubitemid 47076792)
128. Wimmer-Kleikamp, S. H., Nievergall, E., Gegenbauer, K., Adikari, S., Mansour, M., Yeadon, T., et al. (2008). Elevated protein tyrosine phosphatase activity provokes Eph/ephrinfacilitated adhesion of pre-B leukemia cells. Blood, 112, 721-732.
129. Cowan, C.W., Shao, Y. R., Sahin, M., Shamah, S. M., Lin, M. Z., Greer, P. L., et al. (2005). Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron, 46, 205-217. (Pubitemid 40545777)
130. Zimmer, M., Palmer, A., Kohler, J., & Klein, R. (2003). EphBephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nature Cell Biology, 5, 869-878. (Pubitemid 37220692)
131. Marston, D. J., Dickinson, S., & Nobes, C. D. (2003). Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nature Cell Biology, 5, 879-888. (Pubitemid 37220693)
132. Parker, M., Roberts, R., Enriquez, M., Zhao, X., Takahashi, T., Pat, C. D., et al. (2004). Reverse endocytosis of transmembrane ephrin-B ligands via a clathrin-mediated pathway. Biochemical and Biophysical Research Communications, 323, 17-23. (Pubitemid 39200642)
133. Tanaka, M., Sasaki, K., Kamata, R., & Sakai, R. (2007). The Cterminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells. Journal of Cell Science, 120, 2179-2189. (Pubitemid 47074123)
134. Lin, K. T., Sloniowski, S., Ethell, D. W., & Ethell, I. M. (2008). Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. Journal of Biological Chemistry, 283, 28969-28979.
135. Meyer, S., Hafner, C., Guba, M., Flegel, S., Geissler, E. K., Becker, B., et al. (2005). Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. International Journal of Oncology, 27, 1197-1206.
136. Hiramoto-Yamaki, N., Takeuchi, S., Ueda, S., Harada, K., Fujimoto, S., Negishi, M., et al. (2010). Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. The Journal of Cell Biology, 190, 461-477.
137. Noren, N. K., Yang, N. Y., Silldorff, M., Mutyala, R., & Pasquale, E. B. (2009). Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochemistry Journal, 422, 433-442.
138. Hornberger, M. R., Dutting, D., Ciossek, T., Yamada, T., Handwerker, C., Lang, S., et al. (1999). Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons. Neuron, 22, 731-742. (Pubitemid 29203496)
139. Carvalho, R. F., Beutler, M., Marler, K. J., Knoll, B., Becker- Barroso, E., Heintzmann, R., et al. (2006). Silencing of EphA3 through a cis interaction with ephrinA5. Nature Neuroscience, 9, 322-330. (Pubitemid 43290961)
140. Fox, B. P., & Kandpal, R. P. (2011). A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines. Cancer Genomics & Proteomics, 8, 185-193.
141. Marquardt, T., Shirasaki, R., Ghosh, S., Andrews, S. E., Carter, N., Hunter, T., et al. (2005). Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell, 121, 127-139.
142. Campbell, T. N., Davy, A., Liu, Y., Rcellana-Panlilio, M., & Robbins, S. M. (2008). Distinct membrane compartmentalization and signaling of ephrin-A5 and ephrin-B1. Biochemical and Biophysical Research Communications, 375, 362-366.
143. Kao, T. J., & Kania, A. (2011). Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron, 71, 76-91.
144. Wang, B. (2011). Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners. Science Signaling, 4, e28.
145. Astin, J. W., Batson, J., Kadir, S., Charlet, J., Persad, R. A., Gillatt, D., et al. (2010). Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nature Cell Biology, 12, 1194-1204.
146. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., et al. (2006). Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metabolism, 4, 111-121. (Pubitemid 44138718)
147. Edwards, C. M., & Mundy, G. R. (2008). Eph receptors and ephrin signaling pathways: a role in bone homeostasis. International Journal of Medical Sciences, 5, 263-272.
148. Morrissey, C., True, L. D., Roudier, M. P., Coleman, I. M., Hawley, S., Nelson, P. S., et al. (2008). Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clinical & Experimental Metastasis, 25, 377-388.
149. Dong, Y., Mao-Ying, Q. L., Chen, J.W., Yang, C. J.,Wang, Y. Q., & Tan, Z. M. (2011). Involvement of EphB1 receptor/ephrinB1 ligand in bone cancer pain. Neuroscience Letters, 496, 163-167.
150. Azab, F., Azab, A. K., Maiso, P., Calimeri, T., Flores, L. M., Liu, Y., et al. (2012). Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's Macroglobulinemia. Clinical Cancer Research, 18, 91-104.
151. Trinidad, E. M., Ballesteros, M., Zuloaga, J., Zuloaga, J., Zapata, A., & Onso-Colmenar, L. M. (2009). An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression. Blood, 114, 5081-5090.
152. Irie, F., Okuno, M., Matsumoto, K., Pasquale, E. B., & Yamaguchi, Y. (2008). Heparan sulfate regulates ephrin-A3/EphA receptor signaling. Proceedings of the National Academy of Sciences of the United States of America, 105, 12307-12312.
153. Holen, H. L., Zernichow, L., Fjelland, K. E., Evenroed, I. M., Prydz, K., Tveit, H., et al. (2011). Ephrin-B3 binds to a sulfated cell-surface receptor. Biochemistry Journal, 433, 215-223.
154. Garber, K. (2010). Of Ephs and ephrins: companies target guidance molecules in cancer. Journal of the National Cancer Institute, 102, 1692-1694.
155. Nasreen, N., Mohammed, K. A., & Antony, V. B. (2006). Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells. Cancer, 107, 2425-2435. (Pubitemid 44748526)
156. Krasnoperov, V., Kumar, S. R., Ley, E., Li, X., Scehnet, J., Liu, R., et al. (2010). Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. American Journal of Pathology, 176, 2029-2038.
157. Tanaka, M., Kamata, R., Yanagihara, K., & Sakai, R. (2010). Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Science, 101, 87-93.
158. Scehnet, J. S., Ley, E. J., Krasnoperov, V., Liu, R., Manchanda, P. K., Sjoberg, E., et al. (2009). The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood, 113, 254-263.
159. Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., et al. (2002). Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene, 21, 7011-7026. (Pubitemid 35252975)
160. Martiny-Baron, G., Korff, T., Schaffner, F., Esser, N., Eggstein, S., Marme, D., et al. (2004). Inhibition of tumor growth and angiogenesis by soluble EphB4. Neoplasia, 6, 248-257. (Pubitemid 38657081)
161. Moon, J. J., Lee, S. H., & West, J. L. (2007). Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis. Biomacromolecules, 8, 42-49. (Pubitemid 46140471)
162. Djokovic, D., Trindade, A., Gigante, J., Badenes, M., Silva, L., Liu, R., et al. (2010). Combination of Dll4/Notch and Ephrin-B2/ EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer, 10, 641.
163. Martiny-Baron, G., Holzer, P., Billy, E., Schnell, C., Brueggen, J., Ferretti, M., et al. (2010). The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis. Angiogenesis, 13, 259-267.
164. Ansuini, H., Meola, A., Gunes, Z., Paradisi, V., Pezzanera, M., Acali, S., et al. (2009). Anti-EphA2 antibodies with distinct in vitro properties have equal in vivo efficacy in pancreatic cancer. Journal of Oncology, 2009, 951917.
165. Landen, C. N., Jr., Lu, C., Han, L. Y., Coffman, K. T., Bruckheimer, E., Halder, J., et al. (2006). Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. Journal of the National Cancer Institute, 98, 1558-1570. (Pubitemid 44680907)
166. Straume, O., & Akslen, L. A. (2002). Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. American Journal of Pathology, 160, 1009-1019. (Pubitemid 34224589)
167. Easty, D. J., Mitchell, P. J., Patel, K., Florenes, V. A., Spritz, R. A., & Bennett, D. C. (1997). Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. International Journal of Cancer, 71, 1061-1065. (Pubitemid 27252891)
168. Wang, J. D., Dong, Y. C., Sheng, Z., Ma, H. H., Li, G. L., Wang, X. L., et al. (2007). Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis. Oncology, 73, 238-245. (Pubitemid 351630056)
169. Jubb, A. M., Zhong, F., Bheddah, S., Grabsch, H. I., Frantz, G. D., Mueller, W., et al. (2005). EphB2 is a prognostic factor in colorectal cancer. Clinical Cancer Research, 11, 5181-5187. (Pubitemid 41003704)
170. Chiu, S. T., Chang, K. J., Ting, C. H., Shen, H. C., Li, H., & Hsieh, F. J. (2009). Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis, 30, 1475-1486.
171. Cromer, A., Carles, A., Millon, R., Ganguli, G., Chalmel, F., Lemaire, F., et al. (2004). Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene, 23, 2484-2498. (Pubitemid 38520746)
172. Muller-Tidow, C., Diederichs, S., Bulk, E., Pohle, T., Steffen, B., Schwable, J., et al. (2005). Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Research, 65, 1778-1782. (Pubitemid 40478604)
173. Hafner, C., Bataille, F., Meyer, S., Becker, B., Roesch, A., Landthaler, M., et al. (2003). Loss of EphB6 expression in metastatic melanoma. International Journal of Oncology, 23, 1553-1559.
174. Tang, X. X., Zhao, H., Robinson, M. E., Cohen, B., Cnaan, A., London, W., et al. (2000). Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America, 97, 10936-10941.
175. Alam, S. M., Fujimoto, J., Jahan, I., Sato, E., & Tamaya, T. (2009). Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecologic Oncology, 114, 84-88.
176. Alam, S. M., Fujimoto, J., Jahan, I., Sato, E., & Tamaya, T. (2008). Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. British Journal of Cancer, 98, 845-851. (Pubitemid 351272606)
177. Wang, J., Dong, Y., Wang, X., Ma, H., Sheng, Z., Li, G., et al. (2010). Expression of EphA1 in gastric carcinomas is associated with metastasis and survival. Oncology Reports, 24, 1577-1584.
178. Herath, N. I., Spanevello, M. D., Sabesan, S., Newton, T., Cummings, M., Duffy, S., et al. (2006). Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 6, 144.
179. Wang, L. F., Fokas, E., Juricko, J., You, A., Rose, F., Pagenstecher, A., et al. (2008). Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer, 8, 79.
180. Holm, R., Knopp, S., Suo, Z., Trope, C., & Nesland, J. M. (2007). Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis. Journal of Clinical Pathology, 60, 1086-1091. (Pubitemid 47612638)
181. Merritt, W. M., Kamat, A. A., Hwang, J. Y., Bottsford-Miller, J., Lu, C., Lin, Y. G., et al. (2011). Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer Biology & Therapy, 10, 1306-1314.
182. Kamat, A. A., Coffey, D., Merritt, W. M., Nugent, E., Urbauer, D., Lin, Y. G., et al. (2009). EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer, 115, 2684-2692.
183. Miyazaki, T., Kato, H., Fukuchi, M., Nakajima, M., & Kuwano, H. (2003). EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. International Journal of Cancer, 103, 657-663. (Pubitemid 36091471)
184. Alam, S. M., Fujimoto, J., Jahan, I., Sato, E., & Tamaya, T. (2007). Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers. Annals of Oncology, 18, 485-490. (Pubitemid 46359627)